Stefan Uhlig
Overview
Explore the profile of Stefan Uhlig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
4028
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang T, Samapati R, Klassen S, Winoto-Morbach S, Mohamed Z, Goggel R, et al.
Eur Respir J
. 2025 Feb;
PMID: 40015747
Background: Platelet-activating factor (PAF)-induced pulmonary endothelial barrier failure is mediated by acid sphingomyelinase (ASM) translocation to caveolae. ASM, however, lacks a transmembrane domain for anchoring inside caveolae. We hypothesized that...
2.
Rieg A, Suleiman S, Anker C, Bunting N, Verjans E, Spillner J, et al.
Respir Res
. 2022 Jul;
23(1):189.
PMID: 35841089
Background: PDGFR-inhibition by the tyrosine kinase inhibitor (TKI) nintedanib attenuates the progress of idiopathic pulmonary fibrosis (IPF). However, the effects of PDGF-BB on the airway tone are almost unknown. We...
3.
Jiang T, Samapati R, Klassen S, Lei D, Erfinanda L, Jankowski V, et al.
Eur Respir J
. 2022 Apr;
60(4).
PMID: 35450969
Background: Prostaglandin E (PGE) increases pulmonary vascular permeability by activation of the PGE receptor 3 (EP), which may explain adverse pulmonary effects of the EP/EP receptor agonist sulprostone in patients....
4.
Kulkarni H, Lee J, Bastarache J, Kuebler W, Downey G, Albaiceta G, et al.
Am J Respir Cell Mol Biol
. 2022 Feb;
66(2):e1-e14.
PMID: 35103557
Advancements in methods, technology, and our understanding of the pathobiology of lung injury have created the need to update the definition of experimental acute lung injury (ALI). We queried 50...
5.
Fragoulis A, Biller K, Fragoulis S, Lex D, Uhlig S, Reiss L
Int J Mol Sci
. 2021 Aug;
22(15).
PMID: 34360619
qRT-PCR still remains the most widely used method for quantifying gene expression levels, although newer technologies such as next generation sequencing are becoming increasingly popular. A critical, yet often underappreciated,...
6.
Reliability of short-term measurements of heart rate variability: Findings from a longitudinal study
Uhlig S, Meylan A, Rudolph U
Biol Psychol
. 2020 Jun;
154:107905.
PMID: 32505705
Research on heart rate variability (HRV) received increasing attention. This study analysed the reliability of the most common HRV parameters for baseline measurements. 103 healthy students (83 women, M =...
7.
Rieg A, Suleiman S, Bunting N, Verjans E, Spillner J, Schnoring H, et al.
PLoS One
. 2020 May;
15(5):e0233176.
PMID: 32421724
Introduction: Levosimendan is approved for acute heart failure. Within this context, pulmonary hypertension represents a frequent co-morbidity. Hence, the effects of levosimendan on segmental pulmonary vascular resistance (PVR) are relevant....
8.
Reiss L, Raffetseder U, Gibbert L, Drescher H, Streetz K, Schwarz A, et al.
Mediators Inflamm
. 2020 May;
2020:3650508.
PMID: 32410851
Tumor necrosis factor (TNF) is a well-known mediator of sepsis. In many cases, sepsis results in multiple organ injury including the lung with acute respiratory distress syndrome (ARDS). More than...
9.
Boll S, Ziemann S, Ohl K, Klemm P, Rieg A, Gulbins E, et al.
Allergy
. 2019 Sep;
75(3):603-615.
PMID: 31494944
Background: Allergic diseases and especially allergic asthma are widespread diseases with high prevalence in childhood, but also in adults. Acid sphingomyelinase (ASM) is a key regulator of the sphingolipid pathway....
10.
Rieg A, Bunting N, Cranen C, Suleiman S, Spillner J, Schnoring H, et al.
Respir Res
. 2019 Jun;
20(1):111.
PMID: 31170998
Background: Tyrosine kinase inhibitors (TKIs) inhibit the platelet derived growth factor receptor (PDGFR) and gain increasing significance in the therapy of proliferative diseases, e.g. pulmonary arterial hypertension (PAH). Moreover, TKIs...